GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Weekly CFO Buys Highlight: CONSTELLATION ENERGY, DPL Inc., Taylor Capital Group Inc., Physicians Formula Holdings Inc., Response Genetics Inc., MGP Ingredients Inc.

December 19, 2009 | About:
gurujk

gurujk

5 followers
According to GuruFocus Insider Data, the largest CFO buys during the past week were CONSTELLATION ENERGY (CEP), DPL Inc. (DPL), Taylor Capital Group Inc. (TAYC), Physicians Formula Holdings Inc. (FACE), Response Genetics Inc. (RGDX), and MGP Ingredients Inc. (MGPI).

CONSTELLATION ENERGY (CEP): CFO and Treasurer Charles C Ward Bought 32,500 Shares

CFO and Treasurer of CONSTELLATION ENERGY (CEP) Charles C Ward bought 32,500 shares on 12/11/2009 at an average price of $3.31. CONSTELLATION ENERGY PARTNERS LLC, is a limited liability company focused on the acquisition, development and production of oil and natural gas properties, as well as related midstream assets. These reserves are long-lived and low-risk and are well suited for production stability.CEP's business objective is to maximize returns to unitholders, and its growth focus is through acquisition of long-lived, low-risk and predominantly proved developed reserves. Constellation Energy has a market cap of $84.4 million; its shares were traded at around $3.7801 with a P/E ratio of 5.9 and P/S ratio of 0.5.

Constellation Energy reported adjusted earnings of $1.23 per share for the third quarter of 2009, compared with adjusted earnings of $0.76 per share in the same period last year. Adjusted earnings exclude the cumulative effects of changes in accounting principles, discontinued operations and special items (which are defined as significant items that are not related to our ongoing, underlying business or which distort comparability of results). On a generally accepted accounting principles (GAAP) basis, the company reported earnings of $0.69 per share for the third quarter of 2009, compared with a loss of $1.27 per share in the third quarter of 2008. Year-over-year GAAP results were driven primarily by the absence of impairment charges recorded during the third quarter of 2008.

Buy:: President, CEO and COO Stephen R Brunner bought 50,000 shares of CEP stock on 11/19/2009 at the average price of 3.52, the price of the stock has increased by 7.39% since.

DPL Inc. (DPL): SVP, CFO & Treasurer Frederick J Boyle Bought 10,500 Shares

SVP, CFO & Treasurer of DPL Inc. (DPL) Frederick J Boyle bought 10,500 shares on 12/16/2009 at an average price of $28.48. DPL Inc. is a holding company. Its principal subsidiary is The Dayton Power and Light Company. The Dayton Power and Light Company sells electricity and natural gas to residential, commercial and governmental customers in West Central Ohio. Principal industries served include electrical machinery, automotive and other transportation equipment, non-electrical machinery, agriculture, paper, and rubber and plastic products. DPL Inc. has a market cap of $3.34 billion; its shares were traded at around $27.9 with a P/E ratio of 12.5 and P/S ratio of 2.1. The dividend yield of DPL Inc. stocks is 4.1%. DPL Inc. had an annual average earning growth of 2.2% over the past 10 years.

DPL Inc. reported first quarter 2009 earnings of $0.61 per share, compared to $0.66 per share for the same period in 2008. Earnings per share information reported in this press release are based on diluted shares outstanding unless otherwise noted. Total diluted shares outstanding were 112.7 million for the first quarter of 2009 and 116.4 million for the same period in 2008.

DPL is in the portfolios of John Hussman of Hussman Economtrics Advisors, Inc., Louis Moore Bacon of Moore Capital Management, LP, George Soros of Soros Fund Management LLC, Stanley Druckenmiller of Duquesne Capital Management, LLC.

Buy:: President & CEO Paul M Barbas bought 6,000 shares of DPL stock on 12/17/2009 at the average price of 27.84, the price of the stock has increased by 0.22% since. Buy:: SVP, Gen Counsel & Corp Dev Douglas C Taylor bought 3,700 shares of DPL stock on 12/08/2009 at the average price of 28.09, the price of the stock has decreased by 0.68% since. Buy:: SVP, Service Operations Scott J Kelly bought 1,700 shares of DPL stock on 11/10/2009 at the average price of 27.42, the price of the stock has increased by 1.75% since. Buy:: Sr VP and Chief Admin Officer Daniel J Mccabe bought 20,580 shares of DPL stock on 11/02/2009 at the average price of 25.51, the price of the stock has increased by 9.37% since. Sell:: Director Robert D Biggs sold 125,000 shares of DPL stock on 11/16/2009 at the average price of 27.68, the price of the stock has increased by 0.79% since.

Taylor Capital Group Inc. (TAYC): COO and CFO Randall Conte Bought 10,000 Shares

COO and CFO of Taylor Capital Group Inc. (TAYC) Randall Conte bought 10,000 shares on 12/14/2009 at an average price of $7.82. Taylor Capital Group is a bank holding company which derives virtually all of its revenue from its subsidiary, Cole Taylor Bank. Taylor Capital provides a range of products and services concentrating in four primary banking areas: middle-market business banking, small business banking, commercial real estate lending and wealth management. Taylor Capital Group Inc. has a market cap of $98.7 million; its shares were traded at around $8.91 with and P/S ratio of 0.4.

TAYC is in the portfolios of Diamond Hill Capital of Diamond Hill Capital Management Inc.

Buy:: Director Jennifer W Steans bought 277,500 shares of TAYC stock on 12/02/2009 at the average price of 6.52 and 122,500 shares of TAYC stock on 12/02/2009 at the average price of 6.52, the price of the stock has increased by 36.66% since.

Physicians Formula Holdings Inc. (FACE): Int. CFO Jeff M Berry Bought 9,100 Shares

Int. CFO of Physicians Formula Holdings Inc. (FACE) Jeff M Berry bought 9,100 shares on 12/14/2009 at an average price of $1.85. PHYSICIANS FORMULA HOLDINGS, INC. is one of the fastest growing cosmetics companies operating in the mass market prestige, or `masstige,` market. Under its Physicians Formula brand name, the Company develops, markets and distributes innovative, premium-priced products for the mass market channel. Physicians Formula differentiates itself by addressing skin imperfections through a problem-solving approach, rather than focusing on changing fashion trends. Currently, Physicians Formula products are sold throughout the U.S. including stores operated by Wal-Mart, Target, CVS, Walgreens and Kroger. Physicians Formula Holdings Inc. has a market cap of $28.4 million; its shares were traded at around $2.09 with a P/E ratio of 29.7 and P/S ratio of 0.2.

Physicians Formula Holdings, Inc. recently announced financial results for the three months ended September 30, 2009. Net sales were $14.2 million for the third quarter of 2009, compared to $20.3 million for the same period in 2008. Net loss for the third quarter of 2009 was $(0.3) million, or $(0.02) per diluted common share. This compares to net income of $1.7 million, or $0.12 per diluted common share, for the third quarter of 2008. Net sales were down in the third quarter of 2009 versus the prior year period primarily due to two factors: first, the previously announced loss of a major customer, and second, lower Canadian sales relative to the strong increases in distribution that the Company achieved in Canada in 2008. The Company's planned reduction in promotional pre-pack sales, as discussed in both the first and second quarter earnings releases, was also a contributor. The Company also noted that the third quarter has historically been a seasonally low net sales period.

Buy:: CEO Ingrid Jackel bought 10,000 shares of FACE stock on 12/14/2009 at the average price of 1.85, the price of the stock has increased by 12.97% since. Buy:: Director Eiref Zvi bought 5,000 shares of FACE stock on 12/17/2009 at the average price of 2.35, the price of the stock has decreased by 11.06% since. Buy:: President Jeffrey P Rogers bought 19,156 shares of FACE stock on 12/16/2009 at the average price of 1.94, the price of the stock has increased by 7.73% since. Buy:: Director Padraic L. Spence bought 23,200 shares of FACE stock on 12/16/2009 at the average price of 1.93, the price of the stock has increased by 8.29% since. Buy:: Director Charles Hinkaty bought 10,000 shares of FACE stock on 12/15/2009 at the average price of 1.94, the price of the stock has increased by 7.73% since. Buy:: 10% Owner Management Llc Diker bought 25,800 shares of FACE stock on 08/27/2009 at the average price of 2.39, the price of the stock has decreased by 12.55% since.

Response Genetics Inc. (RGDX): Vice President and CFO Thomas Stankovich Bought 7,000 Shares

Vice President and CFO of Response Genetics Inc. (RGDX) Thomas Stankovich bought 7,000 shares on 12/14/2009 at an average price of $1.35. Response Genetics, Inc. is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens. RGI currently generates revenue primarily from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. Response Genetics Inc. has a market cap of $17.4 million; its shares were traded at around $1.14 with and P/S ratio of 2.5.

Physicians Formula Holdings, Inc. recently announced financial results for the three months ended September 30, 2009. Net sales were $14.2 million for the third quarter of 2009, compared to $20.3 million for the same period in 2008. Net loss for the third quarter of 2009 was $(0.3) million, or $(0.02) per diluted common share. This compares to net income of $1.7 million, or $0.12 per diluted common share, for the third quarter of 2008. Net sales were down in the third quarter of 2009 versus the prior year period primarily due to two factors: first, the previously announced loss of a major customer, and second, lower Canadian sales relative to the strong increases in distribution that the Company achieved in Canada in 2008. The Company's planned reduction in promotional pre-pack sales, as discussed in both the first and second quarter earnings releases, was also a contributor. The Company also noted that the third quarter has historically been a seasonally low net sales period.

Buy:: 10% Owner Austin W & Greenhouse Da Marxe bought 2,600 shares of RGDX stock on 07/15/2009 at the average price of 1.1, 1,700 shares of RGDX stock on 07/16/2009 at the average price of 1.14, 200 shares of RGDX stock on 07/22/2009 at the average price of 1.2, 200 shares of RGDX stock on 07/22/2009 at the average price of 1.2, and 200 shares of RGDX stock on 07/22/2009 at the average price of 1.2, the price of the stock has decreased by 5% since.

MGP Ingredients Inc. (MGPI): CFO Don Tracy Bought 5,000 Shares

CFO of MGP Ingredients Inc. (MGPI) Don Tracy bought 5,000 shares on 12/10/2009 at an average price of $7.63. MGP Ingredients is a pioneer in producing and marketing value-added proteins and starches derived primarily from wheat. In addition, they produce natural food-grade alcohol for use in beverage, food and industrial applications, and fuel grade alcohol, commonly known as ethanol. They are headquartered in Atchison, Kansas, and own and operate production facilities in Pekin, Illinois and Kansas City, Kansas. Mgp Ingredients Inc. has a market cap of $156.5 million; its shares were traded at around $9.42 with and P/S ratio of 0.5.

MGPI is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES.

Buy:: Vice President David E Rindom bought 922 shares of MGPI stock on 09/15/2009 at the average price of 3.95 and 10,950 shares of MGPI stock on 09/21/2009 at the average price of 4.1, the price of the stock has increased by 129.76% since. Buy:: Director John R Speirs bought 15,000 shares of MGPI stock on 09/18/2009 at the average price of 4.2, the price of the stock has increased by 124.29% since. Sell:: Vice President Randy M Schrick sold 2,000 shares of MGPI stock on 12/11/2009 at the average price of 7.39, the price of the stock has increased by 27.47% since.

American River Bankshares (AMRB): EVP - CFO Mitchell A Derenzo Bought 3,000 Shares

EVP - CFO of American River Bankshares (AMRB) Mitchell A Derenzo bought 3,000 shares on 12/10/2009 at an average price of $6.25. American River Bankshares is the parent company of American River Bank , a community bank with offices in Sacramento and Placer Counties, that operates a family of financial service providers, including North Coast Bank in Sonoma County and first source capital, a lease financing company in Sacramento. The Banks accept checking and savings deposits, offer money market deposit accounts and certificates of deposit, make secured and unsecured commercial and residential loans, and other installment and term loans, and offer other customary banking services. American River Bankshares has a market cap of $38.5 million; its shares were traded at around $6.65 with a P/E ratio of 11.8 and P/S ratio of 1.1. American River Bankshares had an annual average earning growth of 14.2% over the past 5 years.

American River Bankshares reported net income of $827,000 or $0.14 per diluted share for the third quarter of 2009, compared to $1,931,000 or $0.33 per diluted share for the third quarter of 2008. Net interest income for the third quarter of 2009 decreased $814,000 (12.1%) to $5,928,000 from $6,742,000 for the third quarter of 2008.

Buy:: President & CEO David T Taber bought 2,000 shares of AMRB stock on 12/10/2009 at the average price of 6.25, the price of the stock has increased by 6.4% since. Buy:: Director Roger J Taylor bought 100 shares of AMRB stock on 12/10/2009 at the average price of 6.25, the price of the stock has increased by 6.4% since. Buy:: Director Amdor S Bustos bought 1,000 shares of AMRB stock on 12/10/2009 at the average price of 6.25, the price of the stock has increased by 6.4% since. Buy:: Reg'l Pres. - North Coast Bank Raymond F Byrne bought 1,000 shares of AMRB stock on 12/10/2009 at the average price of 6.25, the price of the stock has increased by 6.4% since. Buy:: Director Charles D Fite bought 10,000 shares of AMRB stock on 12/10/2009 at the average price of 6.25, the price of the stock has increased by 6.4% since. Buy:: Director Robert J Fox bought 48,000 shares of AMRB stock on 12/10/2009 at the average price of 6.25, the price of the stock has increased by 6.4% since.

For the complete list of stocks that bought by their CFOs, go to: Insider Buys.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.3/5 (6 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide